Form 4 for PFE Pfizer
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001225208-22-001256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-02 | 2022-01-31 | PFE | Fonseca Lidia | EVP | F - Tax | $52.69 | -6,680 | 34.7K | -16% | -$352.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | F | D | 6,680 | $52.69 | 34,717 | D | — | — | (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |